Court order

Litigation Update - Knightscope Authorized to Serve Notice of Action Against Capybara Research by Public Disclosure and Press Release Pursuant to Court Order

Retrieved on: 
Friday, March 1, 2024

On December 20, 2023, Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”) filed a federal lawsuit in the United States District Court for the Southern District of New York, Knightscope, Inc. v. Capybara Research et.

Key Points: 
  • On December 20, 2023, Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”) filed a federal lawsuit in the United States District Court for the Southern District of New York, Knightscope, Inc. v. Capybara Research et.
  • 1:23-cv-11050-DLC (the “Action”) against Capybara Research, Igor Appelboom (“Appelboom,” and together with Capybara Research, the “Capybara Defendants”), and Accretive Capital LLC d/b/a Benzinga.
  • View the full release here: https://www.businesswire.com/news/home/20240229740998/en/
    Litigation Update - Knightscope Authorized to Serve Notice of Action Against Capybara Research by Public Disclosure and Press Release Pursuant to Court Order (Graphic: Business Wire)
    The Action alleges that the Capybara Defendants take short positions in publicly traded companies and release fraudulent, disparaging reports in order to drive the company’s stock price down for their own financial benefit.
  • Pursuant to the Order of The Honorable Denise L. Cote in the United States District Court for the Southern District of New York, entered on January 29, 2024 (ECF 29), in the matter of Knightscope, Inc. v. Capybara Research et.

If you paid or incurred George Washington University tuition and/or fees during the Spring 2020 Semester, and the tuition and/or fees have not been refunded in their entirety, you may be eligible to receive cash compensation from a class action settlement

Retrieved on: 
Tuesday, January 9, 2024

A Settlement has been reached in a class action lawsuit between Defendant George Washington University et al.

Key Points: 
  • A Settlement has been reached in a class action lawsuit between Defendant George Washington University et al.
  • What remains of the $5,400,000 will be divided equally among the approximately 18,000 Students in the Settlement Class.
  • Students in the Settlement Class will not need to take any action to receive their shares of the payment.
  • Students in the Settlement Class will automatically receive their shares by check mailed to the Student's last known mailing address.

FP Omni Technologies Announces Its Wind-Down and the Continuation of its $500 Million Lawsuit Against TSYS, a Subsidiary of Global Payments, Inc.

Retrieved on: 
Thursday, December 28, 2023

PEACHTREE CITY, Ga., Dec. 28, 2023 /PRNewswire/ -- FP Omni Technologies, Inc. (fpomnitech.com) has made the decision to wind down its operations.

Key Points: 
  • PEACHTREE CITY, Ga., Dec. 28, 2023 /PRNewswire/ -- FP Omni Technologies, Inc. (fpomnitech.com) has made the decision to wind down its operations.
  • FP Omni believes that, as a result of TSYS' continuing actions and inactions, the company could no longer service its customers properly.
  • FP Omni's wind-down arises out of its inability to continue with the payment processing services promised to FP Omni by TSYS Acquiring Solutions, LLC.
  • The lawsuit is styled FP Omni Technologies v. TSYS Acquiring Solutions, LLC, Superior Court of Gwinnett County, State of Georgia, Civil Action File No.

Acquisition of Abcam by Danaher Approved by the High Court of Justice of England and Wales

Retrieved on: 
Monday, December 4, 2023

The circular in relation to the Scheme was published or made available to Scheme Shareholders on October 5, 2023 (the ‘Scheme Circular‘).

Key Points: 
  • The circular in relation to the Scheme was published or made available to Scheme Shareholders on October 5, 2023 (the ‘Scheme Circular‘).
  • Abcam is pleased to announce that the Court has today issued the Court Order sanctioning the Scheme.
  • The last day of trading in Abcam ADSs on Nasdaq is expected to be December 5, 2023, with trading in Abcam ADSs on Nasdaq being suspended by 8.00 a.m. (Eastern Time) on December 6, 2023.
  • Capitalized terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Scheme Circular.

Hagens Berman Sobol Shapiro LLP Announce a Class Action Which May Affect You If You Had A Health Plan That Paid for Generic Prescription Drugs Purchased at CVS Pharmacy

Retrieved on: 
Friday, November 10, 2023

prescription drugs purchased at CVS Pharmacy, a

Key Points: 
  • prescription drugs purchased at CVS Pharmacy, a
    class action lawsuit could affect your rights.
  • A CLASS ACTION LAWSUIT is pending in the U.S. District Court for the District of Rhode Island (the "Court").
  • Class Plaintiffs contend that they were overcharged for the generic drugs in the HSP program as a result of Defendants' actions.
  • The complete class definitions are available in the LONG-FORM NOTICE on the website www.CVSHSPClassAction.com or by contacting the Notice Administrator.

Wexler Boley & Elgersma LLP, Miller Law LLC, Hilliard Shadowen LLP, Motley Rice LLC, and Spector Roseman & Kodroff P.C. Announce a $30 Million Class Action Settlement for Those Who May Have Purchased or Provided Reimbursement for the Drug Suboxone or Gene

Retrieved on: 
Monday, August 28, 2023

The Court has preliminarily approved a proposed settlement between the Class and Indivior (the "Settlement").

Key Points: 
  • The Court has preliminarily approved a proposed settlement between the Class and Indivior (the "Settlement").
  • The proposed Settlement will provide for the payment of $30 million (the "Settlement Fund") to resolve the Class claims against Indivior.
  • The deadlines contained in this Notice may be amended by Court Order, so check the Settlement website for any updates.
  • SOURCE Wexler Boley & Elgersma LLP, Miller Law LLC, Hilliard Shadowen LLP, Motley Rice LLC, and Spector Roseman & Kodroff P.C.

Girard Sharp LLP and Motley Rice LLC Announce a Proposed Settlement in In re Xyrem (Sodium Oxybate) Antitrust Litigation

Retrieved on: 
Friday, July 28, 2023

The plaintiffs in the lawsuit have reached a proposed Settlement with the Amneal and Lupin defendants that would resolve all claims against them.

Key Points: 
  • The plaintiffs in the lawsuit have reached a proposed Settlement with the Amneal and Lupin defendants that would resolve all claims against them.
  • Separately, the Court has certified several classes of Xyrem and/or Xywav payers and the claims of those classes against the remaining defendants will continue.
  • The proposed Settlement and the Court's class certification order may affect the rights of members of the Settlement Class, the Damages Class and the Injunctive Relief Class (all defined below).
  • But they give up any rights to sue the Defendants separately about the same legal claims in this lawsuit.

Miller Law LLC and Motley Rice LLC Announce a Proposed Settlement in In re Zetia (Ezetimibe) Antitrust Litigation

Retrieved on: 
Tuesday, June 27, 2023

The case name is In re Zetia (Ezetimibe) Antitrust Litigation, Civil Action No.

Key Points: 
  • The case name is In re Zetia (Ezetimibe) Antitrust Litigation, Civil Action No.
  • The Court has preliminarily approved the proposed settlement between the End-Payor Class and Defendants (the “Settlement”).
  • The proposed Settlement will provide for the payment of $70 million (the “Settlement Fund”) to resolve the End-Payor Class claims against Defendants.
  • The full text of the proposed Settlement Agreement, which is dated as of April 19, 2023, is available at www.InReZetiaAntitrustLitigation.com .

Dynamic Technologies Announces Proposed Transaction And Provides Update

Retrieved on: 
Tuesday, June 13, 2023

Dynamic will be seeking the Court’s authority to complete the Transaction on the basis that the Court Order shall be the sole authorization required by Dynamic and its Subsidiaries to proceed with the Transaction.

Key Points: 
  • Dynamic will be seeking the Court’s authority to complete the Transaction on the basis that the Court Order shall be the sole authorization required by Dynamic and its Subsidiaries to proceed with the Transaction.
  • Subject to the granting of the Court Order, no action is required for the existing holders of the equity securities of Dynamic or DSL for the completion of the Transaction.
  • Holders of Dynamic or DSL equity securities who are non-residents of Canada should consult with their tax advisors.
  • MLT Aikins LLP is acting as legal counsel to Dynamic and its Subsidiaries in connection with the CCAA proceedings and the proposed Transaction.

Miller Law LLC and Safirstein Law LLC Announce Proposed Settlements in the Namenda Indirect Purchaser Antitrust Litigation

Retrieved on: 
Monday, December 5, 2022

The proposed settlement with the Generic Defendants includes both consumers and third-party payors (entities such as employers or insurers with self-funded prescription drug plans).

Key Points: 
  • The proposed settlement with the Generic Defendants includes both consumers and third-party payors (entities such as employers or insurers with self-funded prescription drug plans).
  • The settlement with Teva includes the AB-rated generic versions of Namenda IR 5 or 10 mg tablets.
  • If you are a member of one or both classes, you may comment on or object to the proposed settlements.
  • You must object to the settlements by February 3, 2023, or request to be excluded from the class by February 3, 2023.